DexCom (DXCM)

10.79 +0.30  +2.86%  May 25, 5:21PM Go Pro
Watch this stock
View Full Chart DXCM Price Chart

Key Stats

Market Cap 729.73M
Revenue Growth 41.77%
Profit Margin -69.99%
Earnings Yield -6.49%
Dividend Yield 0.00%
Earnings Per Share TTM -0.70
PE Ratio
Price / Sales Ratio 8.879
52 Week High 15.79
52 Week Low 6.75
Beta 1.030
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 08 Listen to $DXCM at deutsche bank ag health care conference - live at 09:20 AM, ondemand after - http://stks.co/3iYr by earningscast
May 07 DexCom Misses on EPS, Losses Mount
May 03 DexCom Beats on Revenue, Matches Expectations on EPS Fool
May 03 Canaccord Genuity Maintains a 'Buy' on DexCom (DXCM); Gen 4 in FDA's Hands Now Street Insider
May 02 Range break long watchlist for tmrw: $CTB $DXCM $TDC $NKE $CF $AGU $PVH $DDS $SLE $CBE $BEAM $JWN $PLCE $JOE $HPQ $CTXS $EQR by TheEquitiesRoom
May 02 $DXCM filed latest Quarterly Report http://stks.co/3dVA by MarketBrief
May 02 DexCom, Inc. (DXCM) Misses Q1 EPS by 2c Street Insider
May 02 DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financi...
May 02 DexCom Inc. Reports First Quarter 2012 Financial Results Business Wire
May 02 Q1 2012 DEXCOM INC Earnings Release - After Market Close
Mar 28 $DXCM amended latest Annual Report http://stks.co/37jd by MarketBrief
Mar 15 $DXCM forms bullish "Continuation Wedge" chart pattern. http://stks.co/2tRo by RecogniaEvents

Profile

Exchange: NASDAQGM       Sector: Healthcare       Industry: Medical Instruments & Supplies

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. The company was founded by John F. Burd in May 1999 and is headquartered in San Diego, CA.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). DexCom is down 27.97% over the last year vs S&P 500 Total Return up 2.57%, Insulet Corporation down 12.85%, and Heartware International up 9.44%.

  • DXCM Total Returns
  • ^SPXTR Total Returns
  • PODD Total Returns
  • HTWR Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Get Quote for

Pro Strategies Featuring DXCM

Did DexCom make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

DXCM Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
DXCM 10.79 +0.30 +2.86% 709.44M
DX 9.35 +0.03 +0.32% 502.23M
DWSN 24.95 +0.07 +0.28% 203.07M
DWM 39.43 +0.07 +0.18%
DWCH 12.23 +0.18 +1.49% 75.19M
DW 26.42 -0.20 -0.75% 594.70M
DVD 1.31 -0.06 -4.38% 50.54M
DV 28.21 +0.31 +1.11% 1.874B
DUSA 5.43 +0.03 +0.56% 128.92M
DUK 21.96 +0.16 +0.73% 28.90B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close